Two thirds of the finalists
for the ‘Most Valuable Patient Initiative’ in the 2015 eyeforpharma Barcelona
Awards have used interactive digital resources or mobile applications to engage
with the patient; a tell-tale sign of the dominance of patient engagement as a
focus for pharma right now. The list of finalists, announced today, includes
Abbvie, AstraZeneca, Bayer, Janssen Healthcare Innovation and Novartis all
vying for the ultimate accolade in pharma; to be crowned ‘most valuable’ to
their patients.
Projects from Abbvie, in
partnership with communications agency Biosector2 and Janssen Healthcare
Innovation, in conjunction with DePuy Synthes and the orthopaedic
department of Guy’s & St Thomas’ Hospital in London, are based around interactive websites which
empower patients to take control of their health and be educated and supported
throughout their relevant treatment, while Bayer Healthcare Turkey stands out
with their Women’s Health TV, developed by 2014 category winner Pelin Icil,
which addresses the issue of poor communication between women and their
gynaecologists in Turkey.
The judges, who include patient representatives Heidi Floyd and Jack
Whelan as well as senior pharmaceutical executives Alberto Grua, Chief
Commercial Officer EU, Australia and North-America and member of the Corporate
Executive Board of Grünenthal and John Pugh, Head of Digital Innovation at
Boehringer Ingelheim favoured projects which could
demonstrate real patient-experience improvement and those which showed a real
understanding of culture and patient-need.
Of Janssen Healthcare Innovation’s Care4Today all-encompassing
initiative, which combines an interactive patient website and a printed
educational pack for hip & knee replacement patient the judges were
unanimously impressed. Patient-judge Heidi Floyd commented: “Guiding
a patient from beginning to end of their surgical journey, stepping through all
the way to end of recovery; magnificent.
As patients, we often are overwhelmed and unable to absorb required data
while preparing for life-changing surgery.
This resource appears to be the perfect tool to allow and encourage
patients to educate themselves about the intense process at their own pace. Health
information such as this will change the future for patients and caregivers
worldwide.”
A comprehensive list of finalists can be found online here: http://www.eyeforpharma.com/barcelona/awards-index.php
Winners will be announced at the 2nd
annual eyeforpharma Barcelona Awards, on Tuesday 24th March 2015 at the
CCIB, Barcelona from 7.30pm, as part of the largest
gathering of pharma executives, eyeforpharma Barcelona. The evening will be attended by the top 200 VIPs from the pharma
industry.
For more information contact Awards Manager, Chloe Leighton on
chloe@eyeforpharma.com or visit
www.eyeforpharma.com/barcelona/awards